These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19421180)

  • 1. An African perspective on mucosal immunity and HIV-1.
    Pala P; Gomez-Roman VR; Gilmour J; Kaleebu P
    Mucosal Immunol; 2009 Jul; 2(4):300-14. PubMed ID: 19421180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective HIV-1 vaccines.
    Belyakov IM; Ahlers JD
    Curr Med Chem; 2011; 18(26):3953-62. PubMed ID: 21824096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental factors in HIV/AIDS epidemic development: new perspectives for gender equity and global protection against HIV transmission.
    Alfsen A
    Ann N Y Acad Sci; 2004 Jun; 1023():164-74. PubMed ID: 15253905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development.
    Belyakov IM; Ahlers JD
    Curr Top Microbiol Immunol; 2012; 354():157-79. PubMed ID: 21203884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate gamma/delta T-cells during HIV infection: Terra relatively Incognita in novel vaccination strategies?
    Agrati C; D'Offizi G; Gougeon ML; Malkovsky M; Sacchi A; Casetti R; Bordoni V; Cimini E; Martini F
    AIDS Rev; 2011; 13(1):3-12. PubMed ID: 21412385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal Vaccination for Prevention of HIV Infection and AIDS.
    Aldovini A
    Curr HIV Res; 2016; 14(3):247-59. PubMed ID: 26957199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do viral and host factors modulate the sexual transmission of HIV? Can transmission be blocked?
    Gupta K; Klasse PJ
    PLoS Med; 2006 Feb; 3(2):e79. PubMed ID: 16492075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections.
    Nikolic DS; Garcia E; Piguet V
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):77-88. PubMed ID: 17266456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of mucosal immunity to HIV-1.
    Jespers V; Harandi AM; Hinkula J; Medaglini D; Le Grand R; Stahl-Hennig C; Bogers W; El Habib R; Wegmann F; Fraser C; Cranage M; Shattock RJ; Spetz AL
    Expert Rev Vaccines; 2010 Apr; 9(4):381-94. PubMed ID: 20370549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal immunology of HIV infection.
    Xu H; Wang X; Veazey RS
    Immunol Rev; 2013 Jul; 254(1):10-33. PubMed ID: 23772612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.
    Herold BC; Mesquita PM; Madan RP; Keller MJ
    Am J Reprod Immunol; 2011 Mar; 65(3):325-33. PubMed ID: 21143689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of microbicides and sexually transmitted infections on mucosal immunity in the female genital tract.
    Keller MJ; Herold BC
    Am J Reprod Immunol; 2006; 56(5-6):356-63. PubMed ID: 17076680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in HIV vaccines inducing mucosal immune responses.
    Pavot V; Rochereau N; Lawrence P; Girard MP; Genin C; Verrier B; Paul S
    AIDS; 2014 Jul; 28(12):1701-18. PubMed ID: 25009956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The situation in Africa.
    Miotti PG; Chiphangwi JD; Dallabetta GA
    Baillieres Clin Obstet Gynaecol; 1992 Mar; 6(1):165-86. PubMed ID: 1633656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.
    Belyakov IM; Ahlers JD
    Trends Immunol; 2008 Nov; 29(11):574-85. PubMed ID: 18838298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of mucosal immunity in prevention of HIV transmission.
    Kozlowski PA; Neutra MR
    Curr Mol Med; 2003 May; 3(3):217-28. PubMed ID: 12699359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immunity against HIV: a priority target for HIV prevention research.
    Borrow P; Shattock RJ; Vyakarnam A;
    Retrovirology; 2010 Oct; 7():84. PubMed ID: 20937128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational Mini-Review Series on Vaccines for HIV: T lymphocyte trafficking and vaccine-elicited mucosal immunity.
    Kaufman DR; Barouch DH
    Clin Exp Immunol; 2009 Aug; 157(2):165-73. PubMed ID: 19604255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal HIV vaccines: a holy grail or a dud?
    Azizi A; Ghunaim H; Diaz-Mitoma F; Mestecky J
    Vaccine; 2010 May; 28(24):4015-26. PubMed ID: 20412879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites.
    Mestecky J
    J Reprod Immunol; 2006 Dec; 72(1-2):1-17. PubMed ID: 17095369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.